{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:29:49Z","timestamp":1793690989419,"version":"4.5.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,27]]},"DOI":"10.7759\/cureus.74611","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:30:35Z","timestamp":1732725035000},"source":"Crossref","is-referenced-by-count":2,"title":["The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Elena","family":"Silverstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Richmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaney","family":"Tyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Fiaoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysia","family":"Treacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Vigliotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schepps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau J","year":"2018","unstructured":"Galipeau J, Sens\u00e9b\u00e9 L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018, 22:824-33. 10.1016\/j.stem.2018.05.004","journal-title":"Cell Stem Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Musia\u0142-Wysocka A","year":"2019","unstructured":"Musia\u0142-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem cell-based therapies. Cell Transplant. 2019, 28:801-12. 10.1177\/0963689719837897","journal-title":"Cell Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.2018.18.03.002","article-title":"Sources and clinical applications of mesenchymal stem cells: state-of-the-art review","volume":"18","author":"Berebichez-Fridman R","year":"2018","unstructured":"Berebichez-Fridman R, Montero-Olvera PR. Sources and clinical applications of mesenchymal stem cells: state-of-the-art review. Sultan Qaboos Univ Med J. 2018, 18:e264-77. 10.18295\/squmj.2018.18.03.002","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxad014","article-title":"The role of lung resident mesenchymal stromal cells in the pathogenesis and repair of chronic lung disease","volume":"41","author":"Doherty DF","year":"2023","unstructured":"Doherty DF, Roets L, Krasnodembskaya AD. The role of lung resident mesenchymal stromal cells in the pathogenesis and repair of chronic lung disease. Stem Cells. 2023, 41:431-43. 10.1093\/stmcls\/sxad014","journal-title":"Stem Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12939","article-title":"Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis","volume":"53","author":"Li Z","year":"2020","unstructured":"Li Z, Niu S, Guo B, et al.. Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis. Cell Prolif. 2020, 53:e12939. 10.1111\/cpr.12939","journal-title":"Cell Prolif"},{"key":"ref6","article-title":"Idiopathic pulmonary fibrosis","author":"Sankari A","year":"2024","unstructured":"Sankari A, Chapman K, Ullah S. Idiopathic pulmonary fibrosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King TE Jr","year":"2011","unstructured":"King TE Jr, Pardo A, Mois\u00e9s S. Idiopathic pulmonary fibrosis. Lancet. 2011, 378:1949-61. 10.1016\/S0140-6736(11)60052-4","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02565-7","article-title":"Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment","volume":"23","author":"Herberts MB","year":"2023","unstructured":"Herberts MB, Teague TT, Thao V, et al.. Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment. BMC Pulm Med. 2023, 23:281. 10.1186\/s12890-023-02565-7","journal-title":"BMC Pulm Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00086606","article-title":"Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches","volume":"28","author":"Raghu G","year":"2006","unstructured":"Raghu G. Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches. Eur Respir J. 2006, 28:463-5. 10.1183\/09031936.06.00086606","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu G","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, et al.. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022, 205:e18-47. 10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.061","article-title":"AAllogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): a phase I safety clinical trial","volume":"151","author":"Glassberg MK","year":"2017","unstructured":"Glassberg MK, Minkiewicz J, Toonkel RL, et al.. AAllogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): a phase I safety clinical trial. Chest. 2017, 151:971-81. 10.1016\/j.chest.2016.10.061","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12343","article-title":"A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Chambers DC","year":"2014","unstructured":"Chambers DC, Enever D, Ilic N, et al.. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014, 19:1013-8. 10.1111\/resp.12343","journal-title":"Respirology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"Tzouvelekis A","year":"2013","unstructured":"Tzouvelekis A, Paspaliaris V, Koliakos G, et al.. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med. 2013, 11:171. 10.1186\/1479-5876-11-171","journal-title":"J Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4222","article-title":"Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: a case report","volume":"13","author":"Zhang C","year":"2017","unstructured":"Zhang C, Yin X, Zhang J, Ao Q, Gu Y, Liu Y. Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: a case report. Exp Ther Med. 2017, 13:1922-6. 10.3892\/etm.2017.4222","journal-title":"Exp Ther Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00773-2020","article-title":"Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial","volume":"7","author":"Campo A","year":"2021","unstructured":"Campo A, Gonz\u00e1lez-Ruiz JM, Andreu E, et al.. Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial. ERJ Open Res. 2021, 7:10.1183\/23120541.00773-2020","journal-title":"ERJ Open Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.19-0037","article-title":"First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline","volume":"9","author":"Averyanov A","year":"2020","unstructured":"Averyanov A, Koroleva I, Konoplyannikov M, et al.. First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline. Stem Cells Transl Med. 2020, 9:6-16. 10.1002\/sctm.19-0037","journal-title":"Stem Cells Transl Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201909_18877","article-title":"Intravenous stem cell dose and changes in quantitative lung fibrosis and DLCO in the AETHER trial: a pilot study","volume":"23","author":"Fishman JE","year":"2019","unstructured":"Fishman JE, Kim GJ, Kyeong NY, Goldin JG, Glassberg MK. Intravenous stem cell dose and changes in quantitative lung fibrosis and DLCO in the AETHER trial: a pilot study. Eur Rev Med Pharmacol Sci. 2019, 23:7568-72. 10.26355\/eurrev_201909_18877","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.3.438","article-title":"Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome","volume":"29","author":"Chang Y","year":"2014","unstructured":"Chang Y, Park SH, Huh JW, Lim CM, Koh Y, Hong SB. Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome. J Korean Med Sci. 2014, 29:438-40. 10.3346\/jkms.2014.29.3.438","journal-title":"J Korean Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/298757-the-application-of-mesenchymal-stem-cell-therapy-in-treating-pulmonary-fibrosis-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:05:38Z","timestamp":1793689538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/298757-the-application-of-mesenchymal-stem-cell-therapy-in-treating-pulmonary-fibrosis-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.74611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}